Johnson & Johnson
Cramer: This is my sport strategy for the 7 days in advance just after Friday’s surprise rally
What the heck definitely did materialize on Friday, when the Dow jumped 700 points on a potent employment looking at ? Why these kinds of a viscerally positive reaction to an employment variety that was hotter than expected? Was it mainly because wages did not spike? Was it all that excellent — a Goldilocks report? […]
Read More
ASCO conference will put the focus on the fight against cancer. These stocks are in the spotlight
Developments in cancer research will be in the spotlight as the American Society of Clinical Oncology hosts the world’s biggest cancer research conference in Chicago, starting Thursday. Investors have already caught a glimpse of the topics that will be discussed but many are eager to hear the details behind the abstracts, and no doubt there […]
Read More
Here are shares to very own to acquire the credit card debt ceiling, bond industry out of your investing equation
Are the travails of the bond current market, like Macbeth expounds, a “tale told by an fool, comprehensive of sound and fury, signifying nothing at all?” As we grapple with the entire edifice of fixed cash flow, the existential crisis of Treasurys, the multitrillion-greenback market that the tale is dependent on, I have come to […]
Read More
Kenvue CEO looks to brand, product innovation to drive growth after IPO
Thibaut Mongon, CEO of Kenvue Inc. a Johnson & Johnson consumer-health business, speaks during an interview with CNBC during his company’s IPO at the New York Stock Exchange (NYSE), May 4, 2023. Brendan McDermid | Reuters Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth at the newly spun-out company […]
Read More
Johnson & Johnson’s consumer health unit Kenvue started trading. What it means for J&J shareholders like us
Johnson & Johnson ‘s (JNJ) consumer-health unit Kenvue (KVUE) soared more than 22% on its first day of trading Thursday, bringing the Club holding one step closer to completing its business separation. The planned split, which is set for later this year, is in the best interest of shareholders of both the soon-to-be-solo Kenvue operations […]
Read More
J&J’s consumer health spinoff Kenvue opens at $25.53, a 16% jump, in public market debut
Thibaut Mongon, CEO and Paul Ruh CFO of Kenvue Inc. a Johnson & Johnson’s consumer-health business, pose together during the company’s IPO at the New York Stock Exchange (NYSE) in New York City, U.S., May 4, 2023. Brendan McDermid | Reuters Johnson & Johnson‘s consumer health spinoff Kenvue jumped 16% in its market debut on […]
Read More
Moderna posts surprise quarterly profit despite waning demand for Covid vaccines
Moderna’s sign is seen outside of their headquarters in Cambridge, MA on March 11, 2021. Boston Globe | Getty Images Moderna on Thursday blew past estimates for first-quarter earnings and revenue, posting a surprise quarterly profit, despite lower demand for Covid vaccines, its only marketable product. The biotech company generated first-quarter sales of $1.9 billion, […]
Read More
FDA approves GSK’s RSV vaccine for older adults, world’s first shot against virus
A GSK lab in London. Oli Scarff | Getty Images The Food and Drug Administration on Wednesday approved an RSV vaccine produced by GlaxoSmithKline for use on adults ages 60 and older. The approval, the first ever globally by a regulatory body for an RSV vaccine, is a decisive victory for GSK in a race […]
Read More
J&J’s consumer health business Kenvue is going public this week. Here’s what to know
Johnson & Johnson products on a shelf in a store in New York. Lucas Jackson | Reuters Johnson & Johnson‘s consumer health business, Kenvue, is expected to go public this week in the largest U.S. IPO in more than a year. That business is chock full of household names familiar to investors and the larger […]
Read More
SoftBank’s Arm registers for blockbuster U.S. IPO
Billionaire Masayoshi Son, chairman and chief government officer of SoftBank Group Corp., speaks in front of a monitor exhibiting the ARM Holdings emblem through a news meeting in Tokyo on July 28, 2016. Tomohiro Ohsumi | Bloomberg | Getty Visuals SoftBank Team Corp’s chip maker Arm has submitted with regulators confidentially for a U.S. inventory […]
Read More